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Abstract: Sport-related brain injury (SRBI) occurs when a blow to the head causes the brain to move
back and forth in the skull, and can lead to neuroendocrine dysfunction. Research has shown that
males and females experience and recover from SRBI differently, yet most of what is known regarding
diagnosis, treatment, and recovery of SRBI is based on male normative data even though females
meet or exceed incidence numbers of SRBIs compared to those of males. Females also have been
known to have worse outcomes and a greater number of symptoms following SRBI than males.
Research is limited as to why females have worse outcomes, but sex hormones have been suggested
as a potential reason. SRBI may cause a dysregulation of the hypothalamic–pituitary–gonadal (HPG)
axis, which is responsible for regulating the sex hormones estrogen and progesterone. Initial research
has shown that SRBI may suppress estrogen and progesterone, and the concentration of these sex
hormones could be indicative of injury severity and recovery trajectory. This review discusses the
sex-specific differences in SRBI and also the future direction of research that is needed in order to
identify the repercussions of SRBIs for female athletes, which will eventually lead to better clinical
treatment, sideline care, and recovery profiles.
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1. Introduction
Since the passage of Title IX in 1972, female sport participation has steadily increased
in the United States. The passage of Title IX mandated, among other things, equal sport
opportunities for females. While this did not lead to equal numbers of males and females
playing all sports, female athlete participation in high-contact and collision sports that
were historically limited to male athletes, such as ice hockey, rugby, and tackle football [1,2]
has increased—and by extension, the number of sport injuries in female athletes has also
increased, including sport-related brain injury (SRBI). Traditionally, it was assumed that
female athletes were less likely to experience SRBIs because their sport participation was
perceived to be less physical. Recent data suggests that the rate of SRBIs in female athletes
meets or exceeds those of male athletes, in sports where both sexes participate [3–6].
SRBIs are caused by a blow to the head or the body, causing the brain to move back
and forth in the skull, resulting in a neurochemical response that activates different parts
of the brain (e.g., originating in the hypothalamus and pituitary gland) to respond to the
sustained trauma [7–9]. The research regarding the complexities of how the hypothalamus
and the pituitary gland react to SRBI is in its infancy. Researchers currently speculate that
disruptions in the hypothalamus and the pituitary gland may result in hypopituitarism.
Hypopituitarism is defined as a deficiency of one or more pituitary-based hormones (e.g.,
estrogen and/or progesterone) [10]. Depending on the severity and magnitude of the SRBI,
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hypopituitarism can cause a withdrawal of hormones such as estrogen and progesterone,
resulting in neuroendocrine dysfunction [11–13]. Neuroendocrine dysfunction is character-
ized by ill-timed hormonal signaling and output, which can impact the timing and patterns
of the menstrual cycle, among other things [11–13]. Over the past two decades SRBI has
received a lot of attention and resources in both the research and clinical realms. Most of
what is known regarding the diagnosis and treatment of, and recovery from SRBI is based
on male normative values, which is problematic given that males and females experience
and recover from SRBI differently [6,14,15].
2. The Need for Sex-Specific Brain Injury Research
Clinical studies have shown that there are sex-based differences at the genetic, cellular,
and physiological levels between males and females [16]. Despite this, numerous stud-
ies [17–19] have reported poor levels of inclusion of female populations in medical research.
In 2016, an Institute of Medicine report showed that females made up less than 40% of
research study populations. This study further reported that when considering animal
research—typically used as the basis for designing and implementing human studies—only
22–40% reported sex as a variable. In addition, females are still severely underrepresented
in sport and exercise medicine research, making up only 39% of research participants [16].
Disparities in the inclusion of females and in the reporting of sex-specific outcomes have
resulted in a significant gap in scientific knowledge and clinical application regarding
female health outcomes, especially within the sports realm. Data now indicates that this is
not the case, as female experiences with SRBIs are vastly different from their male coun-
terparts [20–23]. While data from males can provide guidance and insight into potential
pathophysiological pathways for pursuit, researching biological distinctions between the
sexes or pathophysiological pathways distinct to females (i.e., the menstrual cycle), can
contribute a more nuanced and fine-grained approach to research focused on SRBI, and as
a result, more appropriate sex-specific clinical care. Recently, the examination and inclusion
of biological sex has been emphasized in research design to better understand the extent to
which sex modifies, or influences, the nature and course of recovery following an injury,
including a SRBI [22,24,25]. Biological sex refers to the set of biological attributes in females
and males associated with gene expression, hormone function and chromosomes. The
National Institutes of Health (NIH) has recently identified sex as a biological variable
(SABV) as a factor that may influence the incidence, progression, and outcome in research
and clinical care [26]. NIH’s policy on including SABV in research was implemented since
it has become clear that sex differences need to be researched so that appropriate steps to
establish clinical care for distinctive populations can be realized. Medical and/or biological
research outcomes that are considered “gender neutral” and/or are skewed to male biolog-
ical outcomes, is a missed opportunity to create more appropriate, sex-specific, diagnostics
and treatment approaches that benefit the unique biological make up of females.
3. Sex-Specific Differences in SRBI
The World Health Organization (WHO) estimates that 69 million people will suffer
from a brain injury each year and of those, about 3.8 million injuries will be sustained
through sport/physical activity/recreation participation. The causes of SRBI vary based
on geographical, environmental, biological, and cultural factors. A 2020 report by the
American Academy of Orthopedic Surgeons revealed that despite the increased awareness
among coaches and other stakeholders, efforts to prevent/reduce SRBI have not been fully
realized, and incidences of SRBI continue to rise. Although data are scarce, the existing
literature suggests that the rates of female SRBI are at least as high as those in male athletes
when considering sports where both sexes participate [3–6], indicating that SRBI is a health
concern for both female and male athletes. Furthermore, research also suggests that female
athletes may have worse outcomes than male athletes following a SRBI, as they report a
greater number of symptoms [20,27,28], have higher symptom scores [29], more severe
cognitive declines [28], and are more likely to experience a prolonged recovery [25,30–32].
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Collectively, this research indicates that SRBI does not lead to homogenous outcomes for
males and females, and research investigating factors associated with sexually dimorphic
outcomes following SRBIs is needed.
In 2016, Dr. Brian Hainline, Medical Director of the NCAA said, “Understanding
of the reasons for differences in SRBI between the sexes is poor.” Consensus statements
and position papers concerning SRBIs have been published highlighting the importance
of considering sex differences, preinjury characteristics, and injury-specific variables as
possible modifiers of SRBI outcomes [26,33–35]. Given the increased prevalence of SRBI and
potentially higher levels of symptom reporting among females, research that informs how
biological sex influences the outcomes following SRBI is critical. While numerous studies
on SRBI have compared the outcomes of male and female athletes, research pertaining
to why female athletes have worse outcomes is limited. To date, only a small body of
research [6,27,36] has examined potential mechanisms that may contribute to sex differences
in outcomes following SRBI. Biomechanical mechanisms, related to sex differences in ‘neck
strength to head size’ ratio that make it more challenging for females to stabilize their head
and neck during a head acceleration, have been proposed [37]. Socio-cultural influences,
related to gender socialization in sport whereby female athletes may be more willing to
report SRBI and the severity of symptoms, have also been suggested [6,38]. A novel line of
research, with a growing body of evidence [29,39,40] suggests that female sex hormones
may also influence a female athlete’s experience with SRBI, further supporting the need for
sex-specific research for this topic.
4. Hypopituitarism
Case reports have been published documenting endocrine dysfunction after a trau-
matic brain injury (TBI), which is different from SRBI. A TBI occurs from sudden, violent
trauma (i.e., a car accident), which can cause immediate, life-altering diminished brain
function. SRBI are a type of TBI and are sometimes referred to as mild TBI (mTBI) and
are often considered much less severe in terms of symptoms and recovery time. Research
has recently demonstrated endocrine disruption as a result of external mechanisms that
cause the brain to respond and react inside the skull to an outside force (e.g., a ball to the
head). Endocrine disruption can take on many forms, but one of the most common forms
is hypopituitarism—deficiency of one or more hormones produced and regulated in the
pituitary gland, which can be acute or chronic in nature [10]. The pituitary gland is often
referred to as the “master gland,” because the hormones it produces act as the chemical
regulator for hormone production in other glands [41]. The pituitary gland is roughly the
size of a pea and is divided into two sections: the anterior and posterior. Both sections of
the pituitary gland are connected to the hypothalamus through a stalk of blood vessels and
nerves. Through the stalk, the hypothalamus chemically communicates with the anterior
section of the pituitary gland via hormones, and through the posterior section via nerve
impulses [41].
Hypopituitarism may develop in a female athlete after a single blow to the head or
body or after multiple, repetitive SRBIs. Some research suggests that the likelihood of
developing hypopituitarism after SRBI depends on the severity of the sustained head
trauma, hormone levels at the time of injury, as well as possible genetic influences [42–46].
When SRBI are experienced by a female athlete, disruptive changes to cerebral blood flow
can lead to an overproduction and secretion of hormones in the pituitary gland, resulting in
a cascade of neuroendocrine dysfunction (NED) [47,48]. NED is an indication of hormonal
imbalances and dysregulation that can affect numerous axes related to the hypothalamic–
pituitary connection, but in relation to female athletes, the hypothalamic–pituitary–gonadal
(HPG) axis is of specific interest. The HPG axis is responsible for communicating and
regulating the activities at the intersection of the reproductive and endocrine systems.
In females, the specific topic of interest is the regulation and secretion of the female sex
hormones—estrogen and progesterone [40,44,49,50].
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Both estrogen and progesterone are primarily responsible for regulating the female
reproductive system, including the menstrual cycle, and both originate in the hypothalamic–
pituitary–gonadal axis (HPG axis). Environment (e.g., SRBI) can have a major impact on
the function of the pituitary gland, and by extension the HPG axis, which can disrupt the
regulation and secretion of estrogen and progesterone, negatively affecting the menstrual
cycle [40,51–53]. The relations between SRBI and estrogen and progesterone appear to be
bidirectional; SRBI often leads to the suppression/alteration of estrogen and progesterone,
and the concentration of estrogen and progesterone at the time of the SRBI can be indicative
of the injury severity and recovery trajectory [54]. Since males and females naturally have
different concentrations of sex hormones, with females having higher concentrations of
estrogen and progesterone and males having higher concentrations of testosterone, any
disruption related to the production of these hormones will have different implications for
males and females. Therefore, it can be hypothesized that hormonal deficiencies as a result
of SRBI in females and males are likely to have variable, but significant, effects on brain
function [55].
To date, there are no diagnostic processes or well-established algorithms to screen
for hypopituitarism in female athletes when a SRBI is experienced. This is problematic
since recent research has suggested that hypopituitarism after SRBI may be more common
than once thought and that anterior hypopituitarism is likely to be seen in approximately
25% of female athletes with SRBI [56]. These reduced hormonal outputs from the pituitary
gland are likely to lead to a sequela of neuroendocrine dysfunction, since other glands
(i.e., thyroid, adrenal) and organs (i.e., gonads) that rely on hormones secreted from the
pituitary gland will also be disrupted [53,56].
The production of a normal menstrual cycle in females of child-bearing age relies on
the integration of numerous hormones. In a metronome-like fashion, the hypothalamus
controls the pattern of the menstrual cycle with the pulsatile release of gonadotropin-
releasing hormone (GnRH), which stimulates the pituitary to secrete luteinizing hormone
(LH) and follicle-stimulating hormone (FSH). GnRH is both necessary and sufficient to
drive the menstrual cycle [57]. In practical terms, the pituitary gland translates the pattern
set by the hypothalamus into a hormonal signal (LH and FSH) that the ovary understands—
responding with the production of estrogen and progesterone in varying amounts across the
menstrual cycle [57]. Estrogen and progesterone are produced through key steroidogenic
pathways in the ovary [57] and are critical for female reproductive health and proper
menstrual cycle function in adulthood, but they also contribute to female growth and
development in adolescence and influence bone health, body temperature, cholesterol
production, and nervous system regulation [58–61]. Circulating estrogen and progesterone
feed back to the hypothalamus and pituitary to help control GnRH, LH, and FSH output,
thus providing critical input for normal menstrual cycle function. Given this extraordinarily
intricate system, hypopituitarism secondary to SRBI in females is likely to have widespread
effects on menstrual cycle function and ultimately, if the NED is significant, reproductive
health will also be affected.
5. Progesterone
The steroid hormone progesterone belongs to the progestogens. It is mainly secreted
by the corpus luteum in the ovary during the second half of the menstrual cycle. Several
studies have shown that following SRBI the HPG axis is suppressed, leading to a decrease
in progesterone concentrations [56,62]. Therefore, it appears that, in the wake of SRBI, a
cascade of NED may occur that suddenly decreases the amount of progesterone. Regardless
of menstrual cycle phase, progesterone is normally present in higher concentrations in
the female brain compared to males [63]. Consequently, males experience a less rapid
and overall lower magnitude of progesterone withdrawal following SRBI and overall,
appear less affected by the suppression of the HPG axis and the withdrawal of proges-
terone, compared to females [40,48]. The rapid withdrawal of progesterone experienced
by females following SRBI may partially explain the less optimal clinical outcomes for
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females compared to males following SRBI. Furthermore, since progesterone is a critical
sex hormone for regulating female reproductive health and the menstrual cycle, SRBI have
significant repercussions for female brain and reproductive health [40].
6. Estrogen
Estrogen is secreted by the ovaries in large quantities [57]. Following SRBI, the
pituitary gland may not produce sufficient amounts of LH and FSH, ultimately altering the
production of estrogen [64]. This reduction in estrogen can lead to subsequent reductions
in the stress response, as well as diminished cognitive function [65]. As with progesterone,
the effects of this reduction in estrogen following SRBI appear to be different between
males and females [45]. Sex differences in estrogen concentration levels pre- and post- SRBI,
may therefore have implications for outcomes following head injuries in females [29,66].
As with progesterone, the rapid and significant alterations in estrogen output that could
occur as a downstream outcome of hypopituitarism and NED is under-researched and the
functional consequences are poorly understood [11,29]. Determining the impact of SRBI on
the regulation of estrogen is an important step in examining and determining the short-
and long-term consequences of how SRBI in female athletes differs from how it presents in
their male counterparts. Equally importantly, it is unclear whether SRBI alters the number
or function of estrogen or progesterone receptors in the brain—a further complication that
could significantly alter the menstrual cycle and reproductive health.
7. SRBI and the Menstrual Cycle
Estrogen and progesterone vary across the menstrual cycle, and these fluctuations
have been suggested to be a factor in the onset of and recovery from SRBI seen between
the sexes [11,29]. Specifically, estrogen levels are low at the beginning of the cycle (i.e.,
during menstruation) and then peak prior to ovulation. If an SRBI occurs near the peak of
estrogen, the head trauma may lead to a sudden decrease in estrogen concentration [51,53].
This sudden withdrawal of estrogen can lead to negative outcomes with respect to SRBI
symptoms and recovery in females [29,51,53]. The menstrual cycle and the hormonal
profiles that sustain it are not experienced by men, potentially explaining sex-related
differences after head trauma. Progesterone is low throughout the follicular and ovulatory
phases of the menstrual cycle and then begins to rise during the luteal phase. It peaks in the
middle of the luteal phase, so SRBI sustained during this time can lead to an acute decrease
in progesterone and negative SRBI-related outcomes [29,51,53]. Wunderle et al. (2014)
showed that menstrual phase impacted SRBI symptoms and quality of life health scores,
with those injured during the luteal phase of the menstrual cycle proving worse affected
than females injured during the follicular phase or females taking oral contraceptives (i.e.,
as oral contraceptive users have downregulated levels of estrogen and progesterone). Since
the luteal phase is the time of the highest progesterone levels, these results support the
“withdrawal hypothesis”, which describes SRBI occurring in settings of high progesterone
resulting in sudden decreases—leading to worse outcomes than SRBI occurring in settings
of low progesterone [40]. Thus, it is plausible that SRBI that occur during the ovulatory
phase (due to the peak of estrogen) or in the middle of the luteal phase (due to the peak
of progesterone) could lead to similar negative outcomes. Ripley (2008) found that 90%
of females reported missing periods within the year following brain injury, compared to
just 23% prior to injury, indicating neuroendocrine dysfunction and likely alterations in the
levels of estrogen and progesterone. Severity of SRBI was significantly predictive of longer
durations of amenorrhea, and shorter durations of amenorrhea were predictive of better
outcomes and return to healthy life [62].
8. Future Directions: A Call to Action
Research has demonstrated that female athletes meet or exceed incidence numbers
of SRBIs compared to those of their male counterparts, although the research to date has
focused primarily on male athletes, resulting in a dearth of understanding and clinical
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treatment centered on female athlete symptomology and recovery from SRBIs. Historically,
females were not included in SRBI research because it was believed that females did not
participate in sports where SRBIs were a possible outcome. Given the vast unknown acute
and chronic outcomes of SRBIs in female athletes, as well as the growing numbers of female
athletes in all sports, including ones that were once reserved solely for males, it is no longer
acceptable to exclude female athletes in research designs.
We have identified future research directions that would provide important scientific
insight into the repercussions of SRBIs for female athletes, which will eventually lead to
better clinical treatment, sideline care, and recovery profiles for SRBI in female athletes.
1. Repetitive head trauma, sometimes referred to as sub-concussive trauma, needs to be
examined in female athletes in both the short and long term. Repetitive head trauma
(or sub-concussive head trauma) does not result in diagnosable symptoms (i.e., dizzi-
ness, imbalance), making it extremely difficult to detect and diagnose. Researchers
believe that longitudinal, repetitive head trauma can have serious, detrimental effects
on physical and cognitive health [67–70]. Stern and colleagues at Boston University
are extensively studying repetitive head trauma (sub-concussive trauma) in former
male National Football League (NFL) players and have determined that repetitive
head trauma from sport participation is a risk factor for later life neurocognitive
and neuropsychiatric disease [67–70]. In the United States and around the world,
female athletes are participating in sports where repetitive head trauma is a part of
the sporting environment. Currently, in the United States, it is estimated that there
are around 4000 female tackle football players, participating in two different leagues,
where one league has a 10+ year participation history. The female tackle football
players play by a mix of NFL and National Collegiate Athletic Association (NCAA)
rules. Often, we are asked by female football players, “If I continue to play, will have
the same issues as the former NFL players?”, to which we answer, “We do not know.
Yet. We do not yet know if we will see the same prevalence and severity of head
injuries in female football players as have previously been seen in the NFL.”
2. Some research [11,12] suggests that there are immediate endocrine-based responses
when a female athlete experiences a SRBI. In this review, we identified this concept as
NED. Given the vast responsibilities of the pituitary gland and hypothalamus in the
production and regulation of female sex hormones, it is critical that future research
examines the acute changes in female sex hormones in response to SRBI. While this
review has focused on estrogen and progesterone, it is critical to point out that there
are several other important HPG axis hormones that are vital for the maintenance
of proper menstrual cycle function and reproductive health (i.e., GnRH, LH, FSH)
and little to no research exists on these other hormones. Thus, the menstrual cycle
should be considered a vital sign for females [71] and abrupt changes in menstrual
cycle function should never be ignored in female athletes.
3. The ability to identify novel biomarkers that could be used to detect and/or diagnose
pituitary hormone deficiencies that occur in the acute phase following SRBI requires
studies to elucidate the nuanced changes that occur in both structure and function
of various brain regions and the hormonal alterations that result from these changes.
These novel biomarkers may also help to determine the time course of hormonal
deficiencies that develop as the brain transitions from the acute to the chronic phase
of SRBI. Ultimately, the culmination of these efforts would inform better rehabilitation
and recovery interventions for female athletes.
4. Longitudinal research is critical for understanding the chronic outcomes related to
SRBI in female athletes. What we know about chronic outcomes for SRBI is based
solely on the experiences of male athletes, specifically former NFL players and boxers,
which is problematic given the sex-based differences outlined in this article. Therefore,
it is critical that future research efforts not only track head injury exposure, but also
the long-term physiological and psychological outcomes of such head injuries, which
are likely to impact quality of life in these female athletes.
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5. Even though it is “messy,” the menstrual cycle must be accounted for in biologically
based female athlete research. Research has highlighted that a SRBI disrupts the
menstrual cycle and can lead to irregular menstrual cycles. Importantly, irregular
menstruation can lead to an increased risk for chronic disease and premature mortality
among females. Although the first steps forward in this relatively new area of research
requires assessment of clinically overt impacts on menstrual cycle function, it is critical
to point out that many disruptions in ‘normative’ menstrual cycle function are not
clinically observable. For instance, normative menstrual cycles (i.e., occurring every
26–32 days), are not necessarily indicative of ovulatory cycles. Equally important
is the notion that luteal phase defects can result in reproductive issues even when
ovulatory cycles occur [72]. Nuanced changes in sex-steroid profiles over time may
not produce overt menstrual cycle disruptions and thus, seemingly normal variations
may obfuscate underlying reproductive issues.
6. Given the acute, immediate hormonal response that occurs when a female athlete
experiences a brain injury, future research should investigate how the hormonal
response to brain injury may cause, contribute to, mask, or exacerbate other female-
related performance disorders (i.e., the Female Athlete Triad, REDS).
9. Conclusions
In summary, sport participation impacts multiple facets of wellbeing in female athletes
and while it occurs most often during the early stages of the life span (i.e., reproductive
years), the outcomes of sport participation may have lifelong consequences, both positive
and negative.
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